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The relation of p-aminobenzoic acid to the mode of action of the sulfonamide 
drugs has been discussed in the preceding paper (1).  During the past year the 
theory has been advanced that  sulfapyridine and  suffathiazole  prevent bac- 
terial growth by interfering with the functioning of chemically related coenzyme 
systems.  Fildes  (2)  first called  attention  to the  chemical  relation  of sulfa- 
pyridine  to  nicotinic  acid  and  of sulfathiazole  to  thiamin.  West and  Co- 
burn (3) also noted the similarity of sulfapyridine and nicotinic  acid amide and 
reported in ~itro experiments with Staphylococcus aureus on the basis of which 
they suggested that sulfapyridine exerts its bacteriostatic effect by interfering 
with the forr0ation of cozymase from nicotinamide.  Dorfman and his asso- 
ciates  (4)  observed that  sulfapyridine inhibited  the respiration  of "resting" 
(5) dysentery bacilli and concluded that it acted by disturbing the respiratory 
function of the chemically related vitamin, nicotinamide.  Using pyfidine-3- 
sulfonic acid and its amide, rather than  sulfapyridine, McIlwain (6) showed 
that  sulfonic acid  derivatives  of nicotinic  acid,  when added  to  cultures  of 
Staphylococcus  aureus in a  synthetic medium, inhibited the growth promoted 
by nicotinic acid, nicotinamide,  and cozymase. 
The attractiveness of the hypothesis that the group attached to the sulfon- 
amide radical interferes with the functioning of certain vitamins and coenzymes 
is obvious when one considers  the structural similarity of the compounds in- 
volved.  Sulfapyridine, nicotinic acid, nicotinamide, and cozymase each possess 
a pyridine nucleus.  The thiazole ring common to thiamin and cocarboxylase 
is contained in the sulfathiazole  molecule,  and sulfadiazine  is similarly  related 
to thiamin and cocarboxylase through its pyrimidine radical.  Since nicotinic 
acid, thiamin, and their corresponding coenzymes are known to play important 
r61es in bacterial metabolism (7), it seems logical to assume that they may be 
* This study was supported in part by a grant from The Rockefeller Foundation 
Fluid Research Fund. 
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concerned  in  the  bacteriostatic action of the  chemically related sulfonamide 
compounds. 
To prove the hypothesis, however, it is necessary first to demonstrate that 
the antisulfonamide effect of the vitamin or its coenzyme is specific in the sense 
that it antagonizes only the chemically related suLfonamide drug.  For example 
nicotinic acid and cozymase should inhibit sulfapyridine but not suI/athiazole, 
sulfadiazine, or sulfanilamide.  Thiamin and cocarboxylase, on the other hand, 
should block the action of suLfathiazole and sulfadiazine but should not  influ- 
ence the action of suLfapyridine or sulfanilamide.  The experiments reported 
in  the  present  paper  indicate  that  the  antisuLfonamide  effect  of  thiamin, 
nicotinamide, and their respective coenzymes is in no sense specific and is due 
to stimulation of bacterial growth rather than to a  direct antagonistic action 
upon the suLfonamide drugs.  These observations are discussed in relation to 
the mode of action of the complex derivatives of sulfanilamide, and a tentative 
explanation is offered for the variations in bacteriostatic potency exhibited by 
the different sul/onamide compounds. 
Martial and Mettwds 
Culture Media.--The medium used in all experiments with Staphylococcus aureu~ 
was one of known chemical composition described by Gladstone (8).  The constitu- 
ents of the medium and the several fractions, which  were sterilized separately by 
autoclaving or filtering,  are listed in Table I.  All of the labile fractions (part B) 
were added separately in the order designated.  In the experiments with B. coli the 
medium used was that described in the preceding paper. 
Drug,  Vitamin, and Coenzyrr~ Solutions.--Solutions of the various vitamins and 
coenzymes  1 used in the bacteriological experiments were prepared by dissolving each 
substance either in the basal amino acid fraction of the staphylococcal medium or in 
the synthetic medium for B. toll,  depending upon the organism to be used.  The 
vitamins and  coenzymes tested,  and  the final concentrations  in  which  they were 
employed, are designated below under each experiment.  The  solutious  were  sterib 
ized  by filtration  through  Seitz  filters.  Solutions  of sulfanilamide,  sulfapyridine, 
sulfathiazole, thionine, and methylene blue were prepared in a similar manner except 
that instead of being filtered, the basal medium was brought to a boil just bdore the 
drug was added and the solution was then allowed to cooi slowly without further 
heating.  Stock solutions of the sulfonamide compounds and of methylene blue were 
made up in concentrations of 10  -~ or 10  -3 molar, whereas thionine was prepared in a 
saturated solution.  The desired concentrations for each experiment were attained 
by diluting the stock solutions with the appropriate basal medium. 
Organisms.--The strain  of Staphylococcus aureus  used was one isolated from a 
routine throat culture.  The organism was transferred from blood agar to 5 co. of 
Gladstone's amino acid medium to which nicotinamide and thiamin had been added 
i  n final concentrations of 10  -n and 10  -7 molar respectively.  Excellent growth was 
1 Cocarboxylase and cozymase were supplied through the courtesy of Merck and 
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obtained in this synthetic medium, and daily subcultures were made by adding 0.1 
cc. of a  24 hour culture to 5  cc.  of the medium.  The inoculum used in all  experi- 
TABLE  I 
Culturs Medium for Staphylococcgs aureus 
A. B~I amino acid fraction 
~'I  sPO4 ............................................................. 
Water ................................................................ 
NaOH 1N ........................................................... 
S-Aspartic acid ....................................................... 
S-Vallne  ............................................................. 
S-Leucine ........................................................... 
S-Alanine ........................................................... 
S-Glutamic acid  ..................................................... 
S-Iso-Leucine ......................................................... 
S-Phenylalanine  ...................................................... 
S-Lysine-hydrochloride  ............................................... 
S-Glycine  ........................................................... 
L(--)-Proline ........................................................ 
L(--)-Oxyproline .................................................... 
L(--)-Tyrosine ....................................................... 
L(+)-Arginine hydrochloride ........................................... 
4.5  gin. 
550 ml. 
26 ml. 
0.20 gin. 
0.15 gin. 
0.15 gin. 
0.10 gin. 
0.10 gin. 
0.10 gin. 
0.10 gin. 
0.10 gm. 
0.05 gin. 
0.05 gin. 
0.05 gin. 
0.05 gm. 
0.05 gin. 
Amino acids dissolved in the buffer solution, made up to 600 ml., adjusted to pH 7.40, tubed 
in  3  mi.  quantities  and  autoclaved. 
B. Labile fractions (sdded to each tube separately) 
L(--)-Cystine, x~/200 in N/10 HC1 (Seitz filter) ........................... 
NaOH, N/5 (autoclave) ............................................... 
S-Methionine, M/100 (Seitz filter) ...................................... 
L(--)-Tryptophane, g/200 (autoclave) .................................. 
Glucose, M/2 (Seitz filter) ............................................. 
MgSO~. 7H20, ~s/60 (autoclave) ........................................ 
Fe(NI-Is) s(SO~)2.6HsO,  M/500 in N/50 HCI (Seltz filter) .................... 
Water (autoclave) ..................................................... 
0.10  ml. 
0.05  ml. 
0.10  mi. 
0.05  ml. 
0.05  ml. 
0.125 nil. 
0.125 ml. 
1.4  ml. 
C. Vitamin fraction 
To make a  basal medium for daily subculture and for bacteriostatic experiments, 0.5 cc, of 
a  solution of  10  -~ ~x nicotinamide and l0 t  u  thiamin chloride dissolved in the basal 
amino acid fraction was added to each tube making final concentrations of 10  -6 and 10  "-t 
respectively, 
ments was 0.1  cc.  of a  1:10,000  dilution of the daily subculture.  Plate counts re- 
vealed that the inoculum contained between 10,000 and 20,000 organisms, giving a 
final bacterial concentration of 2,000 to 4,000 viable organisms per cc.  The strain of 
B. coli and the manner in which it was cultured in the synthetic medium have already 
been fully described in the previous paper. 386  ANTIBACTERIAL ACTION OF SULFONAMIDE DRUGS.  H 
EXPERIM~ENTAL 
1. Determination of the Concentrations of Thiamin, Cocarboxylase, Nicotinamide, 
and Cozyraase Optimal for the Growth of Staphylococcus aureus 
Knight's experiments  (9) to determine the quantities of nlcotinamide and of 
thiamin necessary for the optimal growth of the staphylococcus in Gladstone's 
synthetic medium were repeated, and it was found that 10  -~ ~ nicotinamide (or 
cozymase) and 10  -8 M thiamin (or cocarboxylase) would insure heavy growth 
in 42 hours when growth was estimated by noting the degree of clouding in the 
culture tubes.  Growth curves revealed, however, that still higher concentra- 
tions of any of these four substances would cause more rapid multiplication of 
the organism.  (Figs. 1 A, 1 B, and 1 C.)  Knight's assertion that 10  -~ M  nlco- 
tinamide and 10  --7 ~  thiamin enabled optimal growth to occur was, therefore, 
not confirmed in the case of the present strain Of staphylococcus.  That increas- 
ing  concentrations  of  nlcotinamide,  cozymase,  thiamin,  and  cocarboxylase 
accelerate the growth rate of the staphylococcus is a fact of primary importance 
in interpreting the antibacteriostatic effect of these compounds to be described 
below. 
2.  Determination of the Minimum Concentrations of Sulfanilamide, 
Sulfapyridine, Sulfathiazole,  Thiamine, and Methylene  Blue 
That Will Prevent the Growth of Staphylococcus aureus 
The minimum bacteriostatic concentrations of the various drugs used were 
determined by adding increasing  concentrations of drug to successive tubes 
and noting the smallest  concentration that would inhibit growth completely 
for 48 hours. 2  This end point was measured with a reasonable  degree of accu- 
racy by allowing the concentrations in consecutive tubes to vary only within 
relatively narrow limits.  The concentrations of sulfanilamide in several con- 
secutive tubes were, for example, 6 X 10-4~, 4 X 10-4  ~, 2 X 10--4x~, 1 X 10--*~r, 
etc.  The end points of the snlfonamide drugs were very constant when the 
same lots of medium and of drug solution were used.  New medium and new 
drug solution, when standardized, showed a maximum shift in drug end point 
of only one tube.  The dye end points were less constant, showing a tendency 
to shift one or two tubes in successive experiments.  To eliminate the signifi- 
cance of any possible variation, the position of the drug or dye end point was 
checked in all subsequent experiments  dealing with bacteriostasis.  The mini- 
mum bacteriostatic concentrations of the various agents tested are listed in 
Table  II. 
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A.  Growth  curves  of Staphylococcus  aureus  in synthetic medium  containing in- 
creasing concentrations of nicotinamide. 
B.  Growth  curves  of Staphylococcus  aureus  in synthetic medium  containing in- 
creasing concentrations of cozymase. 
C.  Growth curves of Staphylococcus aureus in synthetic medium containing high 
concentrations of thiamin and cocarboxylase. 
D.  Comparison of the growth rates of Staphylococcus aureus  in  10  -3 ~r nicotin- 
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3.  The  Antisulfonamide  Effect  of  Nicotinamide,  Cozymase,  Thiamin,  and 
Cocarboxylase 
When Staphylococcus  aureus  was  used  as  the  test  organism,  it  was found 
possible to block  a the growth-inhibiting  effect of sulfanilamide,  sulfapyridine, 
and  sulfathiazole  with nicotinamide when  the latter  substance  was added to 
the synthetic medium in a concentration of 2 X  10  --~ molar.  Lower concentra- 
tions  of nicotinamide  blocked  more  irregularly  and  a  concentration  of  10  "q 
molar nicotinamide had no blocking effect whatsoever.  Cozymase blocked the 
TABLE II 
Minimum Bacteriostatic Concentrations of Sulfonamide  Drugs, Methylene Blue, and  Tkioniue 
As Tested against Staphylococcus aureus in a S 
Sulfanilamide ........................................ 
Sulfapyridine ........................................ 
Sulfath|a~le ........................................ 
Methylene blue ...................................... 
Thionine ............................................ 
~thetic Medium 
2 X  10-~M 
8X 10-~ 
1 X  10-6~ 
1 X  10  "~ ~r (approximate) 
1:160  dilution  of  saturated 
solution (approximate) 
TABLE III 
Blocking of Bacteriostatic Action of Sul  fapyridine and Sul  fathiazole by Cozymase 
Sulfaw/rid/ne  Sulfathiazole 
Drug concentration  Basal medium  Cozymase IO-~  ~  Drug concentration  Basal reed/urn  Cozymas¢__  I0-4 ~/ 
6 X  10  -6 ~  -t-  -I-  6 X  10- 6~  +  -I- 
8 X  10-~  0  "1-  8 X  i0-6~  0 
1 X  10-~  0  +  1 X  10  -5~r  0 
2X  10  -4~s  0  0  2XlO -~M  0 
+  indicates visible growth of Stapkylococcus aurens at the end of 48 hours. 
growth-inhibiting  action of these  same  drugs far more effectively having an 
antibacteriostatic  effect  at  concentrations  between  10  -~  and  10  -7  molar 
(Table III).  Thiamin and cocarboxylase, on the other hand, manifested only 
a barely detectable antidrug effect even at concentrations as high as 10-  s molar. 
As suggested by the next experiment, this last result may be explained by the 
relatively slight degree of growth stimulation  brought about by thiamin and 
cocarboxylase in the  synthetic medium as compared to that caused by nico- 
tinamide and cozymase. 
In  cultures  of  B.  coli  thiamin  (10-  S ~r),  riboflavin  (10-  5 M),  pyridoxine 
a The term "block" will be used only with reference to the prevention of bacterio- 
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(10-3 u), pantothenic acid (2 X  10  -4 ~), crystallin biotin (3~, per cc.), crystallin 
methyl biotin  4 (3~, per cc.), nicotinamide (10  -a ~s) cocarboxylase 10  -t M) and 
cozymase  10  -~ ~) all failed to exert an antisulfonamide effect.  All of  these 
compounds also failed to increase the antibacteriostatic action of small amounts 
of p-aminobenzoic acid simultaneously added to the medium. 
4.  Correlation of the Antibacteriostatic Action of Nicotinamide,  Cozymase, 
Thiamin, and Cocarboxylase with Their Ability to Stimulate 
Bacterial Growth 
Instead of influencing only the chemically related drug sulfapyridine, nico- 
tinamide  and  cozymase were shown to block the bacteriostatic action of all 
three sulfonamide compounds.  This observation suggested that the blocking 
effect might be due to stimulation of growth rather than to a direct antagonistic 
action upon the drug.  An attempt was made to correlate the antibacterio- 
static  effect of  nicotinamide and  cozymase with  their  ability to  stimulate 
growth.  The  rate  of  growth  of  the  staphylococcus in  basal  medium  was 
compared to that in medium containing from 10--* to 10  -~ molar nicotinamide 
or  from  10  --4  to  10  -~  molar  cozymase.  It  can  be  seen  from the  resulting 
growth curves (Figs. 1 A  and  1 B) that the stimulating effect of cozymase is 
much greater than that of nicotinamide.  As stated above, the limiting block- 
ing concentration of nicotinamide; i.e. the lowest concentration that will reverse 
the inhibition of growth by a  sulfonamide drug, is approximately 10s molar 
whereas that of cozymase is between 10  "-a and 10  -~ molar.  If the growth rates 
of the staphylococcus in 10  -3 molar nicotinamide and in 10  --s molar cozymase 
are plotted on the same graph  (Fig. 1 D), it can be seen that they are approxi- 
mately the same, indicating a close correlation between the growth promoting 
properties and the drug blocking effect of the compounds. 
Similar experiments were also carried out with B. coli grown in the synthetic 
medium described in the preceding paper.  Neither nicotinamide nor cozymase 
is a  growth factor for B. coli as each is for Staphylococcus aureus, and repeated 
growth curves showed that cozymase did not stimulate the growth of B. coli 
in the synthetic medium.  Failing to stimulate growth, cozymase, even in con- 
centrations of 10--4 molar, failed also to block the action of any of the sulfon- 
amide  drugs.  It  appears,  therefore,  that  the  antibacteriostatie  action  of 
nicotinamide and cozymase is dependent upon acceleration of bacterial growth 
rather than upon a direct antidrug effect. 
5.  Lack of Specificity in the Antibacteriostatic Effect of Cozymase 
Quantitative experiments were carried out to determine whether or not the 
blocking effect of cozymase was greater against sulfapyridine to which it is 
4 Obtained through the courtesy of Professor V. du Vigneaud, Cornell University 
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chemically  related than against sulfanilamide  or sulfathiazole  to which  it is 
unrelated.  The degree of blocking by cozymase of each of the compounds was 
found to be approximately the same (Table III). 
To determine whether or not the antibacteriostatic action of cozymase bore 
any specific relation to the sulfonamide group of drugs, cozymase was titrated 
against thionine and methylene blue.  Both of these compounds are dyes which 
probably achieve their bacteriostatic effect by altering the oxidation-reduction 
potential of the culture medium (10), a mechanism apparently quite different 
from that by which  the sulfonamide  drugs act (1).  Cozymase blocked  the 
growth-inhibitory effect of thionine regularly.  Less satisfactory results were 
obtained with methylene blue because of the instability of the bacteriostatic end 
point of this dye, but the general result was the same as with thionine.  These 
experiments  are  compatible  with the view  that the drug-blocking  effect  of 
cozymase is unrelated to the chemical structure of the drug involved and merely 
results from the stimulation of bacterial growth. 
6.  The Failure  of Sulfanilamide,  Sulfapyridine,  and Sulfathiazole to Affect the 
in Vitro Action of Cocarboxylase As a Coemyme 
Cocarboxylase is known to function as a coenzyme in the decarboxylation of 
pyruvate by the  enzyme carboxylase  contained in yeast.  The  activity of 
cocarboxylase may be conveniently estimated by measuring manometrically in 
the  Warburg  apparatus  the  rate  of evolution of  COs  from a  carboxylase- 
cocarboxylase-pyruvate  mixture.  The method employed in the present studies 
was that of Lohmann and Schuster  (11), the reaction being carried out at a 
pH of 6.6.  5  The possible inhibitory action of sulfanilamide, sulfapyridine, and 
sulfathiazole upon the functioning of cocarboxylase was tested by carrying out 
the reaction in the presence of a final concentration of 10 rag. per cent of drug. 
Although sulfathiazole, vchich is chemically related to cocarboxylase, was added 
in concentrations 50 to 200 times greater than that of the coenzyme, it failed 
to influence the reaction.  Sulfanilamide and sulfapyridine likewise were with- 
out effect.  In preliminary unpublished experiments  with sulfapyridine and 
the cozymase-apozymase  system, Walti also  failed  to detect any inhibitory 
effect of the drug upon the action of the coenzyme  (12). 
DISCUSSION 
Direct evidence has been presented in the preceding  paper supporting the 
theory that  the  sulfonamide  drugs prevent bacterial growth by interfering 
5  The dried yeast preparation used as a source of carboxylase and the sodium 
pyruvate were supplied through the courtesy of Dr. Otto Bessy of the Department of 
Biological Chemistry, Harvard  Medical School.  The authors are grateful to Dr. 
C. L. Gemmel  of the Department of Physiology,  Johns Hopkins Medical School, for 
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with the metabolic function of p-aminobenzoic acid.  According to this theory 
there  are  at  least  two  possible  explanations  for  the  fact  that  some  of the 
more  common  derivatives  of  sulfanilamide  are  considerably  more  potent 
bacteriostatic agents than the parent drug.  First,  the greater bacteriostatic 
powers  of  the  substituted  sulfonamide  compounds,  such  as  sulfapyridine, 
sulfathiazole, and sulfadiazine, may be explained by assuming that  the rad- 
ical attached  to  the  sulfonamide group interferes with  the  metabolism of a 
second substance essential to the bacterial cell, just as the p-amino nucleus of 
these  compounds  apparently  disturbs  the  function  of p-aminobenzoic acid. 
Such a dual effect on the part of the more complex derivatives of sulfanilamide 
might well account for their  increased bacteriostatic potency.  Second,  the 
greater antibacterial powers of the substituted  sulfonamide compounds may 
be explained by assuming that the chemical group attached to the sulfonamide 
radical enables the compounds to interfere with the metabolism of p-amino- 
benzoic acid more effectively than  does the  simpler sulfanilamide  molecule. 
According to this second hypothesis the only metabolic function of the bac- 
terial  cell interfered with  by the  sulfonamide  compounds is  that  concerned 
with the utilization of p-aminobenzoic acid, the degree to which this function 
is disturbed determining the relative bacteriostatic potency of the drug. 
The first of these hypotheses has  received support in  the  publications  of 
Dorfman and his coworkers and of West and Coburn, who have advanced the 
view that sulfapyridine specifically alters the metabolism of the pyridine-con- 
raining coenzyme, cozymase.  On purely theoretical grounds the same reason- 
ing might be applied to sulfathiazole and sulfadiazine since both of these com- 
pounds are structurally similar to thiamin and its coenzyme, cocarboxylase. 
The results of the experiments reported in the present paper, however, fail to 
confirm the view that  the  chemical group linked to the sulfonamide radical 
plays a  specific r61e in interfering with either the formation or the function 
of  the  analogous  coenzyme.  It  has  been  shown  that  the  antisulfonamide 
effect of cozymase, emphasized by West and Coburn,  is in no sense specific 
but is due to its action as a growth stimulant rather than to a directly antago- 
nistic action against  the drug.  s  Also the in  vitro  activity of the  coenzyme, 
cocarboxylase, was found to be unaffected by the chemically related sulfon- 
amide compound, sulfathiazole, even when the latter was present in concen- 
t.rations  200  times greater  than  the  coenzyme.  Both  of these  observations 
cast grave doubt upon the attractive theory that the bacteriostatic effect of 
sulfapyridine,  sulfathiazole,  and  sulfadiazine  is  related  to  their  structural 
6 It should be pointed out that p-aminobenzoic acid blocks  efficiently the sulfona- 
mide drugs in a medium in which it fails to stimulate growth (1).  The dissociation 
of growth stimulation and antidrug effect would appear to be fundamental in deter- 
mining whether a given chemical compound is specifically related to the mechanism 
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similarity to nicotinamide, thiamin, and the respective  coenzymes.  The re- 
suits likewise fail to substantiate the view that the greater antibacterial power 
of the more complex sulfonamide drugs is due to a dual effect upon the metab- 
olism of the bacterial cell as  compared to the single effect exerted by the 
simpler sulfanilamide molecule. 
The second hypothesis advanced to explain the differences in bacteriostatic 
potency exhibited by the various common sulfonamide drugs is, on the other 
hand,  entirely compatible  with  the  observations  reported  in  the  previous 
paper,  p-Aminobenzoic acid was shown to block the bacteriostatic effect of 
all of the suifonamide compounds  studied, regardless of their chemical struc- 
ture, and the bacteriostatic potency of each drug was found to be directly 
proportional to  its  ability to  nullify the blocking  effect  of p-aminobenzoic 
acid.  Both of these observations suggest  that all of the sulfonamide  drugs 
studied cause  bacteriostasis  by interfering with a  single metabolic  function 
of the bacterial cell, namely that concerned  with p-aminobenzoic  acid. 
Evidence  has been presented also that the drugs exert their bacteriostatic 
effect by competing with p-aminobenzoic acid for the enzyme system normally 
involved in its utilization.  If the mechanism of bacteriostasis  concerns only 
the competitive inhibition of this particular enzyme system, it must be as- 
sumed  that  the  relative bacteriostatic power  of a  given sulfonamide  drug 
depends upon its relative ability to disturb the function of this essential  sys- 
tem.  Such an assumption is not without foundation for analogous variations 
in  competitive  inhibition by  related  chemical  compounds  are  common  in 
enzyme chemistry.  For example,  Quastel  and Wooldridge  (13) have shown 
that various organic acids having in common the structure 
I  I 
--C  m  --C-- 
I  or  [ 
CH~  ~CH 
L  I 
COOH  COOH 
inhibit  the  important  respiratory  enzyme,  succinic  dehydrogenase.  The 
authors have attributed the inhibition to the structural similarity of these 
compounds and the specific substrate, succinic acid, and have postulated that 
the common chemical configuration causes the inhibitors to become adsorbed 
on to that part of the enzyme surface which normally adsorbs  and activates 
the substrate.  Quastel and Wooldridge have demonstrated in addition that 
all of the related acids  do not cause  the same  degree  of inhibition, the in- 
hibitory effect being  quantitatively different in the case of each compound, 
presumably because of a specific degree of affinity for the enzyme.  Thus the 
present hypothesis advanced to explain the mode of action of the suifonamide 
drugs may be considered exactly analogous  to the competitive inhibition of 
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sulfanilamide and its derivatives, due to their chemical  similarity to p-amino- 
benzoic acid, competitively inhibit the enzyme involved in its utilization and 
that  different sulfonamide  drugs  inhibit  this  essential  enzyme reaction  in 
different degrees. 
To  prove  conclusively  this  "unitarian theory"  as  to  the  mechanism of 
sulfonamide  bacteriostasis  it will be  necessary  first to  identify the enzyme 
system that utilizes p-aminobenzoic acid and secondly to demonstrate that the 
relative bacteriostatic power  of a  given sulfonamide  drug is directly propor- 
tional to its ability to inhibit this particular enzyme system.  An attempt is 
now being made to identify the enzyme (or enzymes)  involved in this appar- 
ently vulnerable cycle of bacterial metabolism. 
SUMMARY 
1.  In cultures of Stapkylococus  aureus  in a synthetic medium nicotinamide 
and cozymase  were  shown  to block  the bacteriostatic action of chemically 
unrelated sulfonamide drugs as well as the chemically related compound sulfa- 
pyridine.  The antibacterial properties  of organic  dyes totally unrelated to 
the sulfonamide compounds  (methylene blue and thionine) were also nullified 
by the addition of cozymase to the culture medium. 
2.  The antagonistic action of the pyridine-containing coenzyme, cozymase, 
was found, by quantitative study, to be no greater against sulfapyridine than 
against other structurally dissimilar  sulfonamide  compounds. 
3.  The  antidrug effects  of nicotinamide and  cozymase  in staphylococcus 
cultures were observed to be directly proportional to their Ability to stimulate 
the growth of the organism in the synthetic medium.  When tested in cultures 
of B.  coli  in which  they failed  to  accelerate  bacterial  growth,  these  same 
substances  failed  to  influence  the  bacteriostatic  action  of  the  sulfonamide 
drugs. 
4.  The in vitro action of the coenzyme, cocarboxylase,  as measured in the 
Warburg respirometer,  was shown to be unaffected by the chemically related 
drug, sulfathiazole, even when the latter was present in great excess. 
The above observations fail to support the theory that sulfapyridine, sulfa- 
thiazole,  and sulfadiazine  prevent bacterial growth by interfering with the 
functioning of the chemically  related coenzymes, cozymase, and cocarboxylase. 
The  mode  of action of sulfanilamide  and  its  more  common derivatives is 
discussed in the light of these observations,  and a tentative theory is offered 
to explain  the differences in bacteriostatic potency exhibited by the various 
sulfonamide  compounds. 
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